{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:39:28Z","timestamp":1793619568908,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-002-097-MY3"],"award-info":[{"award-number":["MOST 106-2314-B-002-097-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To identify and prioritize the influential hub genes in a gene-set or biological pathway, most analyses rely on calculation of marginal effects or tests of statistical significance. These procedures may be inappropriate since hub nodes are common connection points and therefore may interact with other nodes more often than non-hub nodes do. Such dependence among gene nodes can be conjectured based on the topology of the pathway network or the correlation between them.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we develop a pathway activity score incorporating the marginal (local) effects of gene nodes as well as intra-network affinity measures. This score summarizes the expression levels in a gene-set\/pathway for each sample, with weights on local and network information, respectively. The score is next used to examine the impact of each node through a leave-one-out evaluation. To illustrate the procedure, two cancer studies, one involving RNA-Seq from breast cancer patients with high-grade ductal carcinoma in situ and one microarray expression data from ovarian cancer patients, are used to assess the performance of the procedure, and to compare with existing methods, both ones that do and do not take into consideration correlation and network information. The hub nodes identified by the proposed procedure in the two cancer studies are known influential genes; some have been included in standard treatments and some are currently considered in clinical trials for target therapy. The results from simulation studies show that when marginal effects are mild or weak, the proposed procedure can still identify causal nodes, whereas methods relying only on marginal effect size cannot.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The NetworkHub procedure proposed in this research can effectively utilize the network information in combination with local effects derived from marker values, and provide a useful and complementary list of recommendations for prioritizing causal hubs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-020-3444-7","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:02:57Z","timestamp":1584025377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Network hub-node prioritization of gene regulation with intra-network association"],"prefix":"10.1186","volume":"21","author":[{"given":"Hung-Ching","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Pei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-8484","authenticated-orcid":false,"given":"Chuhsing Kate","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"3444_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1039\/c3mb25438k","volume":"9","author":"G Laenen","year":"2013","unstructured":"Laenen G, Thorrez L, Bornigen D, et al. Finding the targets of a drug by integration of gene expression data with a protein interaction network. Mol BioSyst. 2013;9:1676.","journal-title":"Mol BioSyst"},{"key":"3444_CR2","doi-asserted-by":"publisher","first-page":"17417","DOI":"10.1038\/srep17417","volume":"5","author":"Z Isik","year":"2015","unstructured":"Isik Z, Baldow C, Cannistraci CV, et al. Drug target prioritization by perturbed gene expression and network information. Sci Rep. 2015;5:17417.","journal-title":"Sci Rep"},{"key":"3444_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrg3253","volume":"13","author":"Y Moreau","year":"2012","unstructured":"Moreau Y, Tranchevent LC. Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat. Rev. Genet. 2012;13:523\u201336.","journal-title":"Nat. Rev. Genet"},{"key":"3444_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1742-4658.2012.08471.x","volume":"279","author":"RM Piro","year":"2012","unstructured":"Piro RM, Di Cunto F. Computational approaches to disease-gene prediction: rationale, classification and successes. FEBS J. 2012;279:678\u201396.","journal-title":"FEBS J"},{"key":"3444_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/bioinformatics\/btm051","volume":"23","author":"JJ Goeman","year":"2007","unstructured":"Goeman JJ, Buhlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics. 2007;23:980\u20137.","journal-title":"Bioinformatics."},{"key":"3444_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/1471-2164-11-574","volume":"11","author":"DM Gatti","year":"2010","unstructured":"Gatti DM, Barry WT, Nobel AB, et al. Heading down the wrong pathway: on the influence of correlation within gene sets. BMC Genomics. 2010;11:574.","journal-title":"BMC Genomics"},{"key":"3444_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/bib\/bbt002","volume":"15","author":"H Maciejewski","year":"2013","unstructured":"Maciejewski H. Gene set analysis methods: statistical models and methodological differences. Brief Bioinform. 2013;15:504\u201318.","journal-title":"Brief Bioinform"},{"key":"3444_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrg.2016.29","volume":"17","author":"CA de Leeuw","year":"2016","unstructured":"de Leeuw CA, Neale BM, Heskes T, et al. The statistical properties of gene-set analysis. Nat Rev Genet. 2016;17:353\u201364.","journal-title":"Nat Rev Genet"},{"key":"3444_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0962280212460441","volume":"25","author":"P Tamayo","year":"2016","unstructured":"Tamayo P, Steinhardt G, Liberzon A, et al. The limitations of simple gene set enrichment analysis assuming gene independence. Stat Methods Med Res. 2016;25:472\u201387.","journal-title":"Stat Methods Med Res"},{"key":"3444_CR10","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/bioinformatics\/btp460","volume":"25","author":"V Zuber","year":"2009","unstructured":"Zuber V, Strimmer K. Gene ranking and biomarker discovery under correlation. Bioinformatics. 2009;25:2700\u20137.","journal-title":"Bioinformatics."},{"key":"3444_CR11","doi-asserted-by":"publisher","first-page":"W117","DOI":"10.1093\/nar\/gkw365","volume":"44","author":"L Tranchevent","year":"2016","unstructured":"Tranchevent L, Ardeshirdavan A, EIShal S, et al. Candidate gene prioritization with Endeavour. Nucleic Acids Res. 2016;44:W117\u201321.","journal-title":"Nucleic Acids Res"},{"key":"3444_CR12","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen J, Bardes EE, Aronow BJ, et al. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37:W305\u2013411.","journal-title":"Nucleic Acids Res"},{"key":"3444_CR13","doi-asserted-by":"publisher","first-page":"e3874","DOI":"10.1371\/journal.pone.0003874","volume":"3","author":"D Seelow","year":"2018","unstructured":"Seelow D, Schwarz JM, Schuelke M. GeneDistiller-distilling candidate genes from linkage intervals. PLoS One. 2018;3:e3874.","journal-title":"PLoS One"},{"key":"3444_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2105-13-182","volume":"13","author":"C Wu","year":"2012","unstructured":"Wu C, Zhu J, Zhang X. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC Bioinformatics. 2012;13:182.","journal-title":"BMC Bioinformatics."},{"key":"3444_CR15","doi-asserted-by":"publisher","first-page":"e5526","DOI":"10.1371\/journal.pone.0005526","volume":"4","author":"D Nitsch","year":"2009","unstructured":"Nitsch D, Tranchevent LC, Thienpont B, et al. Network analysis of differential expression for the identification of disease-causing genes. PLoS One. 2009;4:e5526.","journal-title":"PLoS One"},{"key":"3444_CR16","doi-asserted-by":"publisher","first-page":"W334","DOI":"10.1093\/nar\/gkr289","volume":"39","author":"D Nitsch","year":"2011","unstructured":"Nitsch D, Tranchevent LC, Goncalves JP, et al. PINTA: a web server for network-based gene prioritization from expression data. Nucleic Acids Res. 2011;39:W334\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3444_CR17","doi-asserted-by":"publisher","first-page":"D412","DOI":"10.1093\/nar\/gkn760","volume":"37","author":"LJ Jensen","year":"2009","unstructured":"Jensen LJ, Kuhn M, Stark M, et al. STRING 8-a global view on protein and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37:D412\u20135.","journal-title":"Nucleic Acids Res"},{"key":"3444_CR18","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3444_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3444_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12859-018-2411-z","volume":"19","author":"SJ Lin","year":"2018","unstructured":"Lin SJ, Lu TP, Yu QY, et al. Probabilistic prioritization of candidate pathway association with pathway score. BMC Bioinformatics. 2018;19:391.","journal-title":"BMC Bioinformatics"},{"key":"3444_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1103\/RevModPhys.74.47","volume":"74","author":"R Albert","year":"2002","unstructured":"Albert R, Barabasi A. Statistical mechanics of complex networks. Rev Mod Phys. 2002;74:47\u201397.","journal-title":"Rev Mod Phys"},{"key":"3444_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"A Barabasi","year":"2004","unstructured":"Barabasi A, Oltvai ZN. Network biology: understanding the cell\u2019s functional organization. Nat Rev Genet. 2004;5:101\u201313.","journal-title":"Nat Rev Genet"},{"key":"3444_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature02555","volume":"430","author":"J Han","year":"2004","unstructured":"Han J, Bertin N, Hao T, et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 2004;430:88\u201393.","journal-title":"Nature."},{"key":"3444_CR24","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1242\/jeb.003731","volume":"210","author":"E Almaas","year":"2007","unstructured":"Almaas E. Biological impacts and context of network theory. J Exp Biol. 2007;210:1548\u201358.","journal-title":"J Exp Biol"},{"key":"3444_CR25","doi-asserted-by":"publisher","first-page":"e61505","DOI":"10.1371\/journal.pone.0061505","volume":"8","author":"P Langfelder","year":"2013","unstructured":"Langfelder P, Mischel PS, Horvath S. When is hub gene selection better than standard meta-analysis? PLoS One. 2013;8:e61505.","journal-title":"PLoS One"},{"key":"3444_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1137\/090761070","volume":"52","author":"E Estrada","year":"2010","unstructured":"Estrada E, Higham DJ. Network properties revealed through matrix functions. SIAM Rev. 2010;52:696\u2013714.","journal-title":"SIAM Rev"},{"key":"3444_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/bioinformatics\/btq131","volume":"26","author":"E Glaab","year":"2010","unstructured":"Glaab E, Baudot A, Krasnogor N, et al. TopoGSA: network topological gene set analysis. Bioinformatics. 2010;26:1271\u20132.","journal-title":"Bioinformatics"},{"key":"3444_CR28","doi-asserted-by":"publisher","first-page":"24666","DOI":"10.1038\/srep24666","volume":"6","author":"CW Chang","year":"2016","unstructured":"Chang CW, Lu TP, She CX, et al. Gene-set analysis with CGI information for differential DNA methylation profiling. Sci Rep. 2016;6:24666.","journal-title":"Sci Rep"},{"key":"3444_CR29","volume-title":"A topology-based pathway analysis under self-contained hypothesis","author":"CP Chu","year":"2017","unstructured":"Chu CP. A topology-based pathway analysis under self-contained hypothesis. Master thesis: National Taiwan University, Taiwan; 2017."},{"key":"3444_CR30","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","volume":"75","author":"MC Abba","year":"2015","unstructured":"Abba MC, Gong T, Lu Y, Lee Y, et al. A molecular portrait of high-grade ductal carcinoma in situ. Cancer Res. 2015;75:3980\u201390.","journal-title":"Cancer Res"},{"key":"3444_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-014-3071-y","volume":"147","author":"ML Slattery","year":"2014","unstructured":"Slattery ML, Lundgreen A, Hines LM, et al. Genetic variation in the JAK\/STAT\/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin\/NSAIDs: the breast Cancer health disparities study. Breast Cancer Res Treat. 2014;147:145\u201358.","journal-title":"Breast Cancer Res Treat"},{"key":"3444_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/bioinformatics\/btg382","volume":"20","author":"JJ Goeman","year":"2004","unstructured":"Goeman JJ, van de Geer AA, de Kort F, et al. A global test for group of genes: testing association with a clinical outcome. Bioinformatics. 2004;20:93\u20139.","journal-title":"Bioinformatics."},{"key":"3444_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici S, Khatri P, Tarca AL, et al. A systems biology approach for pathway level analysis. Genome Res. 2007;17:1537\u201345.","journal-title":"Genome Res"},{"key":"3444_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","volume":"14","author":"PF Christopoulos","year":"2015","unstructured":"Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43.","journal-title":"Mol Cancer"},{"key":"3444_CR35","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1073\/pnas.100566997","volume":"97","author":"AT Ferguson","year":"2000","unstructured":"Ferguson AT, Evron E, Umbricht C, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A. 2000;97:6049\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3444_CR36","doi-asserted-by":"publisher","first-page":"7530","DOI":"10.1038\/ncomms8530","volume":"6","author":"L Phan","year":"2015","unstructured":"Phan L, Chou PC, Velazquez-Torres G, et al. The cell cycle regulator 14-3-3\u03c3 opposes and reverses cancer metabolic reprogramming. Nat Commun. 2015;6:7530.","journal-title":"Nat Commun"},{"key":"3444_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ajpath.2011.12.014","volume":"180","author":"A Shiba-Ishii","year":"2012","unstructured":"Shiba-Ishii A, Noguchi M. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma. Am J Pathol. 2012;180:1653\u201362.","journal-title":"Am J Pathol"},{"key":"3444_CR38","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/cdd.2011.20","volume":"18","author":"A Vilborg","year":"2011","unstructured":"Vilborg A, Bersani C, Wilhelm MT, et al. The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? Cell Death Differ. 2011;18:1434\u201340.","journal-title":"Cell Death Differ"},{"key":"3444_CR39","doi-asserted-by":"publisher","first-page":"15756","DOI":"10.1073\/pnas.0900862106","volume":"106","author":"A Vilborg","year":"2009","unstructured":"Vilborg A, Glahder JA, Wilhelm MT, et al. The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element. Proc Natl Acad Sci U S A. 2009;106:15756\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3444_CR40","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1038\/onc.2013.594","volume":"33","author":"C Bersani","year":"2014","unstructured":"Bersani C, LD XU, Vilborg A, et al. Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3\u03c3. Oncogene. 2014;33:4407\u201317.","journal-title":"Oncogene."},{"key":"3444_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"385","author":"DP Lane","year":"1992","unstructured":"Lane DP. P53, guardian of the genome. Nature. 1992;385:15\u20136.","journal-title":"Nature."},{"key":"3444_CR42","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW. Putting p53 in context. Cell. 2017;170:1062\u201378.","journal-title":"Cell."},{"key":"3444_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9:749\u201358.","journal-title":"Nat Rev Cancer"},{"key":"3444_CR44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"I Bouaoun","year":"2016","unstructured":"Bouaoun I, Sonkin D, Ardin M, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37:865\u201376.","journal-title":"Hum Mutat"},{"key":"3444_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12672-017-0306-5","volume":"9","author":"SM Pejerrey","year":"2018","unstructured":"Pejerrey SM, Dustin D, Kim JA, et al. The impact of ESR1 mutations on the treatment of metastatic breast cancer. Horm Cancer. 2018;9:215\u201328.","journal-title":"Horm Cancer"},{"key":"3444_CR46","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.mce.2013.03.014","volume":"382","author":"S Haricharan","year":"2014","unstructured":"Haricharan S, Li Y. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol Cell Endocrinol. 2014;382:560\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"3444_CR47","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.mce.2013.03.023","volume":"382","author":"PA Furth","year":"2014","unstructured":"Furth PA. STAT signaling in different breast cancer subtypes. Mol Cell Endocrinol. 2014;382:612\u20135.","journal-title":"Mol Cell Endocrinol"},{"key":"3444_CR48","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson DS, Horvath CM. A road map for those who don\u2019t know JAK-STAT. Science. 2002;296:1653\u20135.","journal-title":"Science."},{"key":"3444_CR49","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.mce.2013.03.010","volume":"382","author":"SR Walker","year":"2014","unstructured":"Walker SR, Xiang M, Frank DA. Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer. Mol Cell Endocrinol. 2014;382:616\u201321.","journal-title":"Mol Cell Endocrinol"},{"key":"3444_CR50","doi-asserted-by":"publisher","first-page":"34889","DOI":"10.18632\/oncotarget.26175","volume":"9","author":"EH Dakir","year":"2018","unstructured":"Dakir EH, Pickard A, Srivastava K, et al. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget. 2018;9:34889\u2013910.","journal-title":"Oncotarget."},{"key":"3444_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","volume":"273","author":"J Luo","year":"2009","unstructured":"Luo J. Clycogen synthase kinase 3\u03b2 (GSK3\u03b2) in tumorigenesis and cancer chemotherapy. Cancer Lett. 2009;273:194\u2013200.","journal-title":"Cancer Lett"},{"key":"3444_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.cr.7310078","volume":"16","author":"Q Cao","year":"2006","unstructured":"Cao Q, Lu X, Feng YJ. Glycogen synthase jubase-3\u03b2 positively regulates the proliferation of human ovarian cancer cells. Cell Res. 2006;16:671\u20137.","journal-title":"Cell Res"},{"key":"3444_CR53","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.18632\/oncotarget.2037","volume":"5","author":"JA McCubrey","year":"2014","unstructured":"McCubrey JA, Steelman LS, Bertrand FE, et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014;5:2881\u2013911.","journal-title":"Oncotarget."},{"key":"3444_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2202\/1544-6115.1252","volume":"6","author":"R Opgen-Rhein","year":"2007","unstructured":"Opgen-Rhein R, Strimmer K. Accurate ranking of differentially expressed genes by a distribution-free shrinkage approach. Stat Appl Genet Mol Biol. 2007;6:9.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"3444_CR55","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fgene.2019.01203","volume":"10","author":"S Mubeen","year":"2019","unstructured":"Mubeen S, Hoyt CT, Gem\u00fcnd A, et al. The impact of pathway database choice on statistical enrichment analysis and predictive modeling. Front Genet. 2019;10:1203.","journal-title":"Front Genet"},{"key":"3444_CR56","doi-asserted-by":"publisher","unstructured":"Chowdhury S, Sarkar RR. Comparison of human cell signaling pathway databases-evolution, drawbacks and challenges. Database (Oxford). 2015. https:\/\/doi.org\/10.1093\/database\/bau126.","DOI":"10.1093\/database\/bau126"},{"key":"3444_CR57","first-page":"212693","volume":"5","author":"BL Fridley","year":"2010","unstructured":"Fridley BL, Jenkins GD, Biernacka JM. Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods. PLoS One. 2010;5:212693.","journal-title":"PLoS One"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-3444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-020-3444-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-3444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:07:04Z","timestamp":1615507624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-020-3444-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3444"],"URL":"https:\/\/doi.org\/10.1186\/s12859-020-3444-7","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. All analyses were performed either on publicly available data or on simulation data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}